The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Expansion Is Predicted For The Fluorescent In Situ Hybridization Probe Market Between 2026 And 2030?
The fluorescent in situ hybridization probe market size has shown substantial growth in recent years. It is projected to expand from $1.68 billion in 2025 to $1.8 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.1%. This historical growth can be linked to factors like the limited availability of fluorescent probes, the reliance on conventional single-color FISH, an increasing awareness of genetic diagnostics, rising research funding in molecular biology, and the adoption of fluorescence microscopy.
The fluorescent in situ hybridization probe market size is projected to experience substantial growth in the coming years. It is anticipated to expand to $2.39 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.3%. This projected growth during the forecast period is primarily driven by the development of multiplex and combinatorial barcoded probes, an increase in personalized medicine applications, the expansion of pharmaceutical and biotechnology research, enhanced regulatory compliance and standardization, and the integration of AI-driven image analysis and data analytics. Significant trends for the forecast period include the increasing adoption of FISH probes in clinical diagnostics, the broadening of multiplex and high-throughput screening techniques, their growing use in genetic and agricultural research, integration with advanced imaging and analysis tools, and a focus on custom probe development for personalized medicine.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27289&type=smp
What Drivers Are Influencing The Fluorescent In Situ Hybridization Probe Market?
The growing acceptance of personalized medicine is anticipated to fuel the expansion of the fluorescent in situ hybridization probe market moving forward. Personalized medicine defines a medical framework that employs an individual’s genetic and lifestyle environmental data to customize healthcare and treatments to their particular requirements. The rising preference for personalized medicine stems from people favoring health technologies that provide real-time monitoring and treatment plans uniquely tailored to their biology. Fluorescent in situ hybridization (FISH) probes facilitate personalized medicine by enabling the precise identification of genetic anomalies at the chromosomal level, thereby guiding bespoke therapeutic choices based on a person’s distinct genetic profile. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, noted that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, in contrast to six in 2022. Therefore, the increased integration of personalized medicine is propelling the growth of the fluorescent in situ hybridization probe market.
Which Market Segments Are Examined In The Fluorescent In Situ Hybridization Probe Market Study?
The fluorescent in situ hybridization probe market covered in this report is segmented –
1) By Type: Deoxyribonucleic Acid (DNA) Probes, Ribonucleic Acid (RNA) Probes, Multiplex Probes
2) By Target: Genes, Chromosomes, Other Targets
3) By Technology: Single-Color Fluorescence In Situ Hybridization (FISH), Multiplex Fluorescence In Situ Hybridization (FISH), Quantitative Fluorescence In Situ Hybridization (FISH), Others Technologies
4) By Application: Clinical Diagnostics, Research Applications, Agricultural Biotechnology, Pharmaceutical Research, Genetic Research
5) By End User: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Companies
Subsegments:
1) By Deoxyribonucleic Acid (DNA) Probes: Centromeric Probes, Telomeric Probes, Whole Chromosome Paint Probes, Locus-Specific Identifier (LSI) Probes, Comparative Genomic Hybridization (CGH) Probes, Gene Fusion Probes
2) By Ribonucleic Acid (RNA) Probes: mRNA Probes, Long Non-Coding RNA (lncRNA) Probes, MicroRNA (miRNA) Probes, Single-Molecule RNA FISH Probes (smFISH), Circular RNA (circRNA) Probes, Multiplexed Error-Robust FISH (MERFISH) Probes
3) By Multiplex Probes: Multicolor DNA FISH Probes, Multigene Expression Analysis Probes, High-Throughput Screening Probes, Multiplex smFISH Probes, Combinatorial Barcoded Probes, Simultaneous DNA/RNA Detection Probes
Which Trends Are Influencing The Fluorescent In Situ Hybridization Probe Market?
Companies operating in the fluorescent in situ hybridization probe market are concentrating on forming strategic collaborations to access new markets, technologies, or expertise that might be challenging or expensive to develop on their own. Strategic collaboration refers to a planned partnership involving multiple entities working together by pooling their strengths and resources to achieve common long-term goals and mutual benefits. As an example, in April 2025, Empire Genomics, a US-based molecular diagnostics firm, collaborated with BioDot, a US-based provider of precision dispensing automation, to introduce the BDot Probe Line. The BDot Probe Line offers a distinct solution by supplying FISH probes pre-optimized for automated systems, tackling a major obstacle in clinical cytogenetics and molecular pathology labs. These probes are designed for direct application without requiring manual modifications, ensuring smooth operation with the Biodot CellWriter S system. This innovation decreases the need for technician input, streamlines processes, and shortens the time required to obtain results. The initial set of BDot Probe Panels supports FISH analysis for a wide array of blood-related cancers, such as MM, MDS, CML, AML, ALL, and other prevalent hematologic conditions.
Who Are The Primary Competitors In The Fluorescent In Situ Hybridization Probe Market?
Major companies operating in the fluorescent in situ hybridization probe market are Thermo Fisher Scientific Inc., Abbott Laboratories, Oxford Gene Technology IP Limited, Sigma-Aldrich Co. LLC, Agilent Technologies Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Leica Biosystems Nussloch GmbH, Biocare Medical LLC, Enzo Biochem Inc., LGC Biosearch Technologies, ZytoVision GmbH, Creative Biolabs Inc., Empire Genomics LLC, MetaSystems GmbH, Abnova Corporation, Mirus Bio LLC, Genemed Biotechnologies Inc., Molecular Instruments Inc., Cytocell Technologies Limited.
Read the full fluorescent in situ hybridization probe market report here:
Which Regions Are Expected To Experience Rapid Expansion In The Fluorescent In Situ Hybridization Probe Market?
North America was the largest region in the fluorescent in situ hybridization probe market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fluorescent in situ hybridization probe market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Fluorescent In Situ Hybridization Probe Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27289&type=smp
Browse Through More Reports Similar to the Global Fluorescent In Situ Hybridization Probe Market 2026, By The Business Research Company
Motor Insurance Market Report 2026
https://www.thebusinessresearchcompany.com/report/motor-insurance-global-market-report
Home Insurance Market Report 2026
https://www.thebusinessresearchcompany.com/report/home-insurance-global-market-report
Embedded Insurance Market Report 2026
https://www.thebusinessresearchcompany.com/report/embedded-insurance-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model